A61P 9 - Drugs for disorders of the cardiovascular system

Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
11/2006
11/23/2006	US20060264420 Tteating cell proliferation disease by modulation of kinesin and treatment of cancer
11/23/2006	US20060264397 Compositions and methods for targeting cancer cells
11/23/2006	US20060264363 Inhibition of nerve cell death by inhibiting degradation of shc3, atf6 or crebl1 by htra2 and method of ameliorating neurodegenerative diseases
11/23/2006	US20060263849 The analogs are resistant to diaminopeptidase IV degradation and bind zinc; are active over an extended time in vivo
11/23/2006	US20060263827 Novel endothelial cells, antibodies directed against said cells and use thereof, in particular for screening angiogenesis inhibiting substances
11/23/2006	US20060263447 Treating pulmonary disorders with gaseous agent causing repletion of GSNO
11/23/2006	US20060263422 Pharmaceutical composition containing decoy and use of the same
11/23/2006	US20060263407 Deliver platelet rich plasma, sodium bicarbonate, calcium gluconate, choline chloride buffers, thrombin, collagen, epinephrine releasate, via catheter; stent implants
11/23/2006	US20060263392 Method for treating neovascularization
11/23/2006	US20060263369 Administering an antibody that selectively binds to the extracellular region of human magic roundabout (MR); inhibiting angiogenesis
11/23/2006	US20060263359 Diagnostics and therapeutics for diseases associated with dopamine receptor d4 (drd4)
11/23/2006	US20060263341 Selected cell delivery for heart failure
11/23/2006	US20060263301 In situ gelling self-reactive materials for embolization
11/23/2006	DE60202452C5 Pyridazinonaldose reductase inhibitoren Reductase inhibitors Pyridazinonaldose
11/23/2006	CA2611506A1 Nanoparticulate and controlled release compositions comprising a platelet aggregation inhibitor
11/23/2006	CA2609117A1 A1 adenosine receptor agonists
11/23/2006	CA2609102A1 Int6 protein involved in hypoxia stress induction and use thereof
11/23/2006	CA2608718A1 1, 2, 4-triazole derivatives as vasopressin antagonists
11/23/2006	CA2608690A1 Stable tablet containing droxidopa
11/23/2006	CA2608539A1 Process for preparing 3.alpha.(.beta.)-7.alpha.(.beta.)-dihydroxy-6.alpha.(.beta.)-alkyl-5.beta.-cholanic acid
11/23/2006	CA2608447A1 Oxidative stress inhibitor
11/23/2006	CA2607472A1 Antipyretic agents against vr1-antagonist-induced increases in body temperature
11/23/2006	CA2607325A1 The use of rapamycin derivatives for the treatment and/or prevention of cardiovascular disorders
11/22/2006	EP1724279A2 5-Beta-sapogenin and pseudosapogenin derivatives and their use in the treatment of dementia.
11/22/2006	EP1724278A1 Nitrogenous fused-ring derivatives, medicinal compositions containing the derivatives, and use thereof as drugs
11/22/2006	EP1724277A1 Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof
11/22/2006	EP1724270A2 Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents
11/22/2006	EP1724267A1 Pyrimidine derivative
11/22/2006	EP1724264A1 Nitriles and medicinal compositions containing the same as the active ingredient
11/22/2006	EP1724259A1 2,7-substituted 5-amino-4-hydroxy-8-(1h-indazol-5-yl)-octan amide derivatives and related compounds as renin inhibitors for the treatment of hypertension
11/22/2006	EP1724258A1 Heteroarylphenylurea derivative
11/22/2006	EP1724257A1 Medicinal composition for prevention or treatment of overactive bladder accompanying nervous disorder
11/22/2006	EP1723968A1 Erythrocyte function modifying substance
11/22/2006	EP1723956A1 Preventive or therapeutic agents for severe diabetic retinopathy
11/22/2006	EP1723955A1 Medicine for prevention and/or treatment of ischemic circulatory disease
11/22/2006	EP1723954A1 Indazole derivatives for the treatment of cancer
11/22/2006	EP1723163A2 Isopeptide gap junction modulators
11/22/2006	EP1723148A2 Thieno-imino acid derivatives for use as matrix metalloproteinase inhibitors
11/22/2006	EP1723129A1 1-akan-2-ol substituted piperazine and piperidine compounds
11/22/2006	EP1723105A1 Bicyclic substituted indole-derivative steroid hormone nuclear receptor modulators
11/22/2006	EP1722799A2 Treatment of pulmonary artery hypertension with dhea, dheas, dhea analogs or dhea derivatives
11/22/2006	EP1722767A2 NON-PEPTIDYL AGENTS WITH pHSP20-LIKE ACTIVITY, AND USES THEREOF
11/22/2006	EP1551860B1 Glucocorticoid receptor ligands for the treatment of metabolic disorders
11/22/2006	EP1509520B1 Use of benzo(c)quinolizinium derivatives for the treatment of diseases that are linked to smooth muscle cell constriction
11/22/2006	EP1501798A4 SULFONYLAMINOVALEROLAC TAMS AND DERIVATIVES THEREOF AS FACTOR Xa INHIBITORS
11/22/2006	EP1483271B1 Heterocyclic amide derivatives having glycogen phosphorylase inhibitory activity
11/22/2006	EP1467982B1 Glucocorticoid mimetics, methods of making them, pharmaceutical formulations containing them, and uses thereof
11/22/2006	EP1461034B1 Substituted imidazolidines, method for the production thereof, use thereof as a drug or for diagnosis, and drug containing substituted imidazolidines
11/22/2006	EP1459738A4 Pharmaceutical composition having thrombolytic, anti-inflammatory and cytoprotective properties
11/22/2006	EP1458721B1 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino [4,5-b]indole-1-carboxamide derivatives, their preparation and therapeutic use
11/22/2006	EP1458683B1 Heteroaryl-substituted aminocyclohexane derivatives
11/22/2006	EP1438055A4 D-tagatose as an anti-biofilm agent
11/22/2006	EP1438049B1 Substituted 4-phenyl-4-(1h-imidazol-2-yl)-piperidine derivatives for reducing ischaemic damage
11/22/2006	EP1432402B1 Compositions for delivery of drug combinations
11/22/2006	EP1401413B1 Use of tyrosine kinase inhibitions for treating allergic diseases
11/22/2006	EP1360186B1 Carboline derivatives
11/22/2006	EP1351933B1 Il-8 receptor antagonists
11/22/2006	EP1317450B1 Pyrazole compounds useful as protein kinase inhibitors
11/22/2006	EP1315482B1 Water-dispersible encapsulated sterols
11/22/2006	EP1298132B1 Hydropyridine derivative acid addition salts
11/22/2006	EP1294757B1 Glucagon-like peptide-1 analogs
11/22/2006	EP1282444B1 Antithrombotic agents
11/22/2006	EP1268435B1 4,5-dihydro-1h-pyrazole derivatives having cb 1-antagonistic activity
11/22/2006	EP1173465B1 Novel human voltage-gated potassium channel
11/22/2006	EP1051395B1 N-hydroxyformamide derivatives
11/22/2006	EP1051176B1 SUBSTITUTED OXOAZAHETEROCYCLYL FACTOR Xa INHIBITORS
11/22/2006	EP1035131B1 Process for the preparation of n2 -(1(s)-carboxy-3-phenylpropyl)-l-lysyl-l-proline
11/22/2006	EP0939821B1 G-beta-gamma regulated phosphatidylinositol-3' kinase
11/22/2006	EP0935415B1 In vitro methods for delivering nucleic acids into a cell
11/22/2006	CN1867578A The conjugates of a hydrophilic polymer-buxus's extracts and the pharmaceutical compositions of thereof
11/22/2006	CN1867351A Remedy for kidney diseases
11/22/2006	CN1865248A Imidazole-4-carboxamide derivatives, preparation and use thereof for treatment of obesity
11/22/2006	CN1864739A A medicine for treating cardiovascular and cerebrovascular disease
11/22/2006	CN1864738A A medicine for treating angina pectoris
11/22/2006	CN1864731A Anti-thrombosis blood fat-reducing blood pressure-decreasing oral liquid
11/22/2006	CN1864728A Prescription and preparation method of yin-nourishing capsule containing ginseng and astragalus root
11/22/2006	CN1864720A Solanummammosum
11/22/2006	CN1864717A Method for extracting Chinese lantern plant steride and pharmaceutical composition thereof
11/22/2006	CN1864716A Prescription of collateral-dredging capsule with astragalus root and earthworm and preparation method thereof
11/22/2006	CN1864711A Drop pills for treating coronary heart disease and preparation method thereof
11/22/2006	CN1864701A A Chinese medicinal membrane agent capable of being dissolved rapidly in oral cavity and preparation method thereof
11/22/2006	CN1864696A New formulation
11/22/2006	CN1864694A Oral disintegrating tablet of notoginseng triterpenes and preparation method thereof
11/22/2006	CN1864690A Preparation of cyclovirobuxinum D
11/22/2006	CN1864687A Compound blood pressure reducing preparation
11/22/2006	CN1864680A Oral disintegrating tablet of trimetazidine and preparation method thereof
11/22/2006	CN1864677A An anti-thrombus anti-restenosis composite medicine coated on eluting stent
11/22/2006	CN1864675A Use of naringenin and derivative in preparation of product for resisting cardiovascular and cerebrovascular disease
11/22/2006	CN1864673A A levo-carnitine for injection and preparation method thereof
11/22/2006	CN1864663A Pharmaceutical compositions of 5,7,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2 (11),3,5,7,9-pentaene
11/22/2006	CN1864547A A tea mixed coffee with glossy ganoderma and method for preparing same
11/22/2006	CN1864542A Organic potassium supplementation preparation made from compound Chinese herbs for hypertension control
11/22/2006	CN1285580C Pyrimidine compounds
11/22/2006	CN1285578C Substituted benzoic acid amides and use for inhibition of angiogenesis thereof
11/22/2006	CN1285572C Cannabinod receptor ligands
11/22/2006	CN1285362C Medicine for treating bleeding due to piles and other anorectal disease and the preparation method thereof
11/22/2006	CN1285361C Health caring medical liquor containing wine processed grape
11/22/2006	CN1285354C Medicine for treating cerebral infarction
11/22/2006	CN1285353C Freeze dried genseng and prepared aconite root powder injecta and its preparation
11/22/2006	CN1285344C Method for preparing acanthopanax injectio

1 ... 662 663 664 665 666 667 668 669 670 671 672 673 674 675 676 677 678 679 680 681 682 ... 1595